US President Trump Signs Order to Fast-Track Psychedelic Drug Review
US President Donald Trump has signed an executive order aimed at accelerating the review process for a number of psychedelic drugs, including the controversial ibogaine. The signing ceremony in the Oval Office on Saturday featured podcaster Joe Rogan, who is considered one of the most influential podcasters in the country and a leading proponent of ibogaine, a substance derived from a plant native to West Africa. Rogan recounted how he had previously texted information about ibogaine to Trump, with the president purportedly responding quickly: “Sounds great. Do you want FDA (Food and Drug Administration) approval? Let’s do it.”











